CRL · Earnings call · 2026Q2T · Full report
Operating Cash Flow Trends
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 64 · Surprise 40 · From source text
Second-quarter free cash flow was $149 million, down $21 million from the prior-year period. The decline was primarily caused by working-capital timing rather than a deterioration in operating performance. Full-year free-cash-flow guidance increased to $400 million–$420 million from $375 million–$400 million. The higher outlook is largely driven by increased earnings.
Key facts
- Free cash flow guidance for the full year was raised to $400 million to $420 million from a prior outlook of $375 million to $400 million, largely driven by higher earnings.
- Free cash flow was $149 million in the second quarter, a decrease of $21 million compared to the prior year period, primarily driven by the timing of working capital.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -0.3% | Free cash flow was $149 million in the second quarter, a decrease of $21 million compared to the prior year period, primarily driven by… |
| cash | positive | committed | +0.3% | Free cash flow guidance for the full year was raised to $400 million to $420 million from a prior outlook of $375 million to $400 million,… |